Immunobiological properties of inactivated anti-highly pathogenic avian influenza vaccines based on antigens of А/Н5N1 avian influenza virus strains of different virulence

Antigen of H5N1 low pathogenic avian influenza virus Yamal strain included in the inactivated emulsion vaccine is able to induce strong immunity against highly pathogenic avian influenza in chickens. Inactivated emulsion vaccines based on antigen of H5N1 low pathogenic avian influenza virus Yamal strain and antigen of H5N1 highly pathogenic avian influenza virus А/chicken/Primorsky/85/08 strain are capable of inducing dose-dependent cross immunity against current Н5N1 and H5N8 highly pathogenic avian influenza viruses. Thus, inoculation dose of H5N1 low pathogenic avian influenza virus Yamal strain antigen required for pro­tection of 95% of chickens against H5N1 highly pathogenic avian influenza virus А/chicken/Primorsky/85/08 strain and against H5N8 highly pathogenic avian influenza virus A/duck/KChR/1590-20/20 in the vaccine inoculation volume shall be at least 609 HAU and 255 HAU, respectively. The inoculation dose of H5N1 highly pathogenic avian influenza virus А/chicken/Primorsky/85/08 strain antigen for protection from H5N8 highly pathogenic avian influenza virus A/duck/KChR/1590-20/20 strain shall be at least 294 HAU. Protective effect of the tested inactivated vaccines was associated with humoral immunity level in poultry. Predicted titre of antibodies to homologous virus antigens conferring expected 95% protection of vaccinated poultry was 1:538 or 9.1 log2. Inactivated vaccine based on H5N1 low pathogenic avian influenza virus Yamal strain antigen demonstrates its high immunogenicity in chickens infected with Н5N1 and Н5N8 highly pathogenic avian influenza influenza virus.

1. Avian influenza (including infection with pathogenicity avian influenza viruses). In: WOAH. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.4. Available at: https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.03.04_AI.pdf (date of access: 28.02.2022).

2. Zinyakov N. G., Andriyasov A. V., Ovchinnikova Ye. V., Kozlov A. A., Zhestkov P. D., Andreychuk D. B., Chvala I. A. Analysis of marker substitutions in A/chicken/Astrakhan/2171-1/2020 H5N8 isolate of avian influenza virus recovered in the Astrakhan Oblast. Veterinary Science Today. 2021; (2): 132–137. DOI: 10.29326/2304-196X-2021-2-37-132-137.

3. Zecchin B., Goujgoulova G., Monne I., Salviato A., Schivo A., Slavcheva I., et al. Evolutionary dynamics of H5 highly pathogenic avian influenza viruses (clade 2.3.4.4B) circulating in Bulgaria in 2019–2021. Viruses. 2021; 13 (10):2086. DOI: 10.3390/v13102086.

4. World Health Organization. Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness = Caractéristiques génétiques et antigéniques des virus grippaux A zoonotiques et mise au point de virus vaccinaux candidats pour se préparer à une pandémie. Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire. 2021; 96 (12): 88–104. Available at: https://apps.who.int/iris/handle/10665/340335.

5. Tian J., Li M., Bai X., Li Y., Wang X., Wang F., et al. H5 low pathogenic avian influenza viruses maintained in wild birds in China. Vet. Microbiol. 2021; 263:109268. DOI: 10.1016/j.vetmic.2021.109268.

6. Akshalova P. B., Zinyakov N. G., Andriyasov A. V., Zhestkov P. D., Nikonova Z. B., Kolosov S. N., Chvala I. A. Genetic analysis of nucleotide sequences of neuraminidase gene of highly pathogenic avian influenza A/H5N8 virus isolates recovered in the Russian Federation in 2020. Veterinary Science Today. 2021; 10 (4): 301–307. DOI: 10.29326/2304-196X-2021-10-4-301-307.

7. Brugh M., Beard C. W., Stone H. D. Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines. Am. J. Vet. Res. 1979; 40 (2): 165–169. PMID: 464352.

8. Lee C. W., Senne D. A., Suarez D. L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 2004; 78 (15): 8372–8381. DOI: 10.1128/JVI.78.15.8372-8381.2004.

9. Kayali G., Kandeil A., El-Shesheny R., Kayed A. S., Gomaa M. R., Kutkat M. A., et al. Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt? Poult. Sci. 2013; 92 (1): 114–118. DOI: 10.3382/ps.2012-02637.

10. Poetri O. N., Van Boven M., Koch G., Stegeman A., Claassen I., Wayan Wisaksana I., Bouma A. Different cross protection scopes of two avian influenza H5N1 vaccines against infection of layer chickens with a heterologous highly pathogenic virus. Res. Vet. Sci. 2017; 114: 143–152. DOI: 10.1016/j.rvsc.2017.04.005.

11. Lewis N. S., Banyard A. C., Whittard E., Karibayev T., Al Kafagi T., Chvala I., et al. Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020. Emerg. Microbes. Infect. 2021; 10 (1): 148–151. DOI: 10.1080/22221751.2021.1872355.

12. Shichinohe S., Okamatsu M., Yamamoto N., Noda Y., Nomoto Y., Honda T., et al. Potency of an inactivated influenza vaccine prepared from a non-pathogenic H5N1 virus against a challenge with antigenically drifted highly pathogenic avian influenza viruses in chickens. Vet. Microbiol. 2013; 164 (1–2): 39–45. DOI: 10.1016/j.vetmic.2013.01.041.

13. Swayne D. E., Lee C.W., Spackman E. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathology. 2006; 35 (2): 141–146. DOI: 10.1080/03079450600597956.

14. Irza V. N., Volkov M. S., Varkentin A. V., Frolov S. V., Altunin D. A. The protective features of domestic serial and experimental vaccines with regard to highly pathogenic avian influenza of H5N1 and H5N8 types isolated in 2015–2016. Poultry & Chicken Products. 2017; 6: 12–18. eLIBRARY ID: 30731041. (in Russ.)

15. Kapczynski D. R., Pantin-Jackwood M. J., Spackman E., Chrzastek K., Suarez D. L., Swayne D. E. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses. Vaccine. 2017; 35 (46): 6345–6353. DOI: 10.1016/j.vaccine.2017.04.042.

16. Poetri O. N., Van Boven M., Koch G., Stegeman A., Claassen I., Wayan Wisaksana I., Bouma A. Different cross protection scopes of two avian influenza H5N1 vaccines against infection of layer chickens with a heterologous highly pathogenic virus. Res. Vet. Sci. 2017; 114: 143–152. DOI: 10.1016/j.rvsc.2017.04.005.

17. Swayne D., Sims L. Avian influenza. In: Veterinary Vaccines: Principles and Applications. Ed. by S. Metwally, G. Viljoen, A. El Idrissi. 1st ed. Chichester: John Wiley & Sons Limited; FAO; 2021; Chapter 18: 229–251. Available at: https://www.fao.org/3/cc2031en/cc2031en.pdf.

18. Sachs L. Statiatische Auswertungsmethoden. Berlin: Springer-Verlag; 1972. 545 s. DOI: 10.1007/978-3-662-10037-0. (in German)

19. Förster E., Rönz B. Methoden der Korrelations- und Regressionsanalyse. Berlin: Die Wirtschaft; 1979. 324 s. (in German)

20. Van der Waerden B. L. Mathematische Statistik. Berlin: Springer-Verlag; 1957. 360 s. (in German)

21. Urbakh V. Yu. Statistical analysis in biological and medical research. Moscow: Medicina; 1975. 297 p. (in Russ.)